171 related articles for article (PubMed ID: 34951635)
1. Clinical Value of Serum Levels of 11-Oxygenated Metabolites of Testosterone in Women With Polycystic Ovary Syndrome.
Tosi F; Villani M; Garofalo S; Faccin G; Bonora E; Fiers T; Kaufman JM; Moghetti P
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2047-e2055. PubMed ID: 34951635
[TBL] [Abstract][Full Text] [Related]
2. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
O'Reilly MW; Kempegowda P; Jenkinson C; Taylor AE; Quanson JL; Storbeck KH; Arlt W
J Clin Endocrinol Metab; 2017 Mar; 102(3):840-848. PubMed ID: 27901631
[TBL] [Abstract][Full Text] [Related]
3. Excess 11-Oxygenated Androgens in Women With Severe Insulin Resistance Are Mediated by Adrenal Insulin Receptor Signaling.
Walzer D; Turcu AF; Jha S; Abel BS; Auchus RJ; Merke DP; Brown RJ
J Clin Endocrinol Metab; 2022 Aug; 107(9):2626-2635. PubMed ID: 35696182
[TBL] [Abstract][Full Text] [Related]
4. Discriminatory Value of Steroid Hormones on Polycystic Ovary Syndrome and Clustering of Hyperandrogenism and Metabolic Factors.
Wang Z; Van Faassen M; Groen H; Cantineau AEP; Van Oers A; Van der Veen A; Hawley JM; Keevil BG; Kema IP; Hoek A
Endocr Pract; 2024 Apr; 30(4):348-355. PubMed ID: 38244859
[TBL] [Abstract][Full Text] [Related]
5. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
[TBL] [Abstract][Full Text] [Related]
6. Conversion of Classical and 11-Oxygenated Androgens by Insulin-Induced AKR1C3 in a Model of Human PCOS Adipocytes.
Paulukinas RD; Mesaros CA; Penning TM
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35560164
[TBL] [Abstract][Full Text] [Related]
7. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis.
Altinkilic EM; du Toit T; Sakin Ö; Attar R; Groessl M; Flück CE
J Steroid Biochem Mol Biol; 2023 Oct; 233():106366. PubMed ID: 37499841
[TBL] [Abstract][Full Text] [Related]
8. Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism.
Di Sarra D; Tosi F; Bonin C; Fiers T; Kaufman JM; Signori C; Zambotti F; Dall'Alda M; Caruso B; Zanolin ME; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2013 Jun; 98(6):2581-8. PubMed ID: 23596136
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X
Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
[TBL] [Abstract][Full Text] [Related]
10. Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome.
Tosi F; Fiers T; Kaufman JM; Dall'Alda M; Moretta R; Giagulli VA; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2016 Feb; 101(2):610-8. PubMed ID: 26695861
[TBL] [Abstract][Full Text] [Related]
11. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
12. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
Salameh WA; Redor-Goldman MM; Clarke NJ; Mathur R; Azziz R; Reitz RE
Fertil Steril; 2014 Apr; 101(4):1135-1141.e2. PubMed ID: 24534279
[TBL] [Abstract][Full Text] [Related]
13. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.
Jedel E; Gustafson D; Waern M; Sverrisdottir YB; Landén M; Janson PO; Labrie F; Ohlsson C; Stener-Victorin E
Psychoneuroendocrinology; 2011 Nov; 36(10):1470-9. PubMed ID: 21549510
[TBL] [Abstract][Full Text] [Related]
14. Serum Androgens Are Independent Predictors of Insulin Clearance but Not of Insulin Secretion in Women With PCOS.
Tosi F; Dal Molin F; Zamboni F; Saggiorato E; Salvagno GL; Fiers T; Kaufman JM; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32119099
[TBL] [Abstract][Full Text] [Related]
15. Salivary testosterone measurement in women with and without polycystic ovary syndrome.
Sathyapalan T; Al-Qaissi A; Kilpatrick ES; Dargham SR; Adaway J; Keevil B; Atkin SL
Sci Rep; 2017 Jun; 7(1):3589. PubMed ID: 28620242
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
[TBL] [Abstract][Full Text] [Related]
17. Determination of urinary androgens in women with polycystic ovary syndrome using LC-QqQ/MS and the application of thin film solid-phase microextraction (TF-SPME).
Rajska A; Raczak-Gutknecht J; Struck-Lewicka W; Buszewska-Forajta M; Wityk P; Verding P; Kowalewska A; Siluk D; Rachoń D; Jan Markuszewski M
J Chromatogr A; 2024 Mar; 1718():464735. PubMed ID: 38364619
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
[TBL] [Abstract][Full Text] [Related]
19. 11-Oxygenated C19 Steroids Do Not Distinguish the Hyperandrogenic Phenotype of PCOS Daughters from Girls with Obesity.
Torchen LC; Sisk R; Legro RS; Turcu AF; Auchus RJ; Dunaif A
J Clin Endocrinol Metab; 2020 Nov; 105(11):e3903-9. PubMed ID: 32797203
[TBL] [Abstract][Full Text] [Related]
20. High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.
Münzker J; Lindheim L; Adaway J; Trummer C; Lerchbaum E; Pieber TR; Keevil B; Obermayer-Pietsch B
Clin Endocrinol (Oxf); 2017 Apr; 86(4):567-575. PubMed ID: 28039871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
